What is Biogen and can they repair their reputation?
World of DTC Marketing
SEPTEMBER 24, 2021
This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. He has zero credibility with the HCP community.
Let's personalize your content